Completed NA INTERVENTIONAL NCT00129688

Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children

Comparison of Efficacy, Safety and Economic Outcomes Between Once-Daily Versus Twice-Daily Amikacin in Combination With Cloxacillin in Febrile Neutropenic Children

Sponsor: Khon Kaen University

Conditions Cancer Fever Neutropenia

Interventions cloxacillin and amikacin (once or twice daily dosage)

Updated 5 times since 2017 Last updated: Sep 22, 2005 Started: Apr 30, 2002 Completion: Jun 30, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cancer and Fever, this trial is completed. The trial is conducted by Khon Kaen University and has accumulated 5 data snapshots since 2002. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Khon Kaen University
National Research Council of Thailand

Data source: Khon Kaen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.